Ranolazin Krka d.d. 375 mg tablete s produljenim oslobađanjem
| Name | Ranolazin Krka d.d. 375 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-117553040 |
| Active Substance | ranolazin |
| Composition | svaka tableta s produljenim oslobađanjem sadrži 375 mg ranolazina |
| Pharmaceutical Form | Tableta s produljenim oslobađanjem |
| Manufacturer | TAD Pharma Gmbh, Cuxhaven, Njemačka
Krka d.d., Novo mesto, Novo Mesto, Slovenija |
| Marketing Authorisation Holder | Krka d.d., Novo mesto, Šmarješka cesta 6, Novo Mesto, Slovenija |
| Marketing Authorisation Date | 03.02.2023 |
| MA Period of Validity | 03.02.2028 |
| Classification Number | UP/I-530-09/21-01/352 |
| Registration Number | 381-12-01/171-23-10 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C01EB18 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
